NEPH1 Antibodies

Santa Cruz Biotechnology delivers a wide array of NEPH1 monoclonal antibodies for investigating NEPH1's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NEPH1, or Nephrin, is a crucial component involved in the formation and maintenance of the slit diaphragm in podocytes, which are specialized cells in the kidney. NEPH1 maintains the filtration barrier of the glomerulus, and its dysfunction is associated with various kidney diseases, including nephrotic syndrome. Research focused on NEPH1 continues to reveal new insights about renal pathologies and potential therapeutic approaches. Scientists worldwide rely on NEPH1 monoclonal antibodies to advance their understanding of kidney biology and disease mechanisms. Ongoing studies of NEPH1 are uncovering important details about podocyte function and glomerular filtration. NEPH1 monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to nephrology research and the development of kidney disease treatments.